CDNA (CareDx, Inc.) Stock Analysis - Hedge Fund Holdings
CareDx, Inc. (CDNA) is a publicly traded Healthcare sector company. As of May 21, 2026, CDNA trades at $21.15 with a market cap of $1.06B and a P/E ratio of -132.13. CDNA moved +2.92% today. Year to date, CDNA is +6.76%; over the trailing twelve months it is +19.22%. Its 52-week range spans $10.96 to $32.97. Analyst consensus is buy with an average price target of $24.73. Rallies surfaces CDNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns CDNA stock?
Hedge funds tracked by Rallies that own CDNA include Exoduspoint Capital. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for CareDx, Inc..
CDNA Key Metrics
Key financial metrics for CDNA
Metric
Value
Price
$21.15
Market Cap
$1.06B
P/E Ratio
-132.13
EPS
$-0.16
Dividend Yield
0.00%
52-Week High
$32.97
52-Week Low
$10.96
Volume
0
Avg Volume
0
Revenue (TTM)
$412.82M
Net Income
$-8.19M
Gross Margin
0.00%
Top Hedge Funds Holding CDNA
Exoduspoint Capital holds 31.24K shares of CDNA, changed -32.00% as of Dec 31, 2025.
Hedge funds tracked by Rallies that own CDNA include Exoduspoint Capital. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for CareDx, Inc..
Does Rallies show 13F holders for CDNA?
Yes. Rallies tracks hedge fund and 13F ownership data for CDNA, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CDNA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CDNA. It does not provide personalized investment advice.
